The Finnish Medicines Agency Fimea, the Finnish Environment Institute (SYKE) and the Finnish Food Authority are responsible for the supervision of the Gene Technology Act in practice.

Finnish Medicines Agency Fimea supervises the contained use of GMOs and in health matters also the deliberate releases. The Finnish Environment Institute supervises the deliberate releases in environmental matters, and the Finnish Food Authority supervises the deliberate releases in matters concerning agriculture and forestry.

The Board for Gene Technology leads and coordinates the supervision. As necessary, the Board also orders which authority is competent in a matter related to deliberate releases. The inspection procedures under the Gene Technology Act are provided in the Decree 198/2007 of the Ministry of Social Affairs and Health.

 

The supervision committee of the Board for Gene Technology has drawn up instructions in Finnish for the product supervision of GM plants.